TP53 and type 1 diabetes mellitus: Here we demonstrated for the first time in the mouse model of type 1 diabetes conditions that p53 also directly increases the expression of MDM2 and recruits MDM2 to HIF-1α, thereby facilitating its ubiquitin-dependent proteasomal degradation and inhibiting its transactivation properties under DM conditions.